Read Japanese companies, in a consistent order.
JII Compounders organizes the way overseas institutional investors analyze Japanese listed companies in a consistent order for each company. Before considering what is attracting attention, we ask how the operating business is valued, how much profit it generates from the capital it uses, and what remains unclear to investors.
This page explains six viewpoints used across our company reports. IR teams can use them to understand what overseas investors examine; investors can use them to compare Japanese companies on a consistent basis.
Before P/E, remove cash and look at the value of the operating business.
Many Japanese companies hold substantial cash. Market capitalization alone makes it difficult to see how the market values the operating business itself.
Many Japanese listed companies, particularly mid-sized companies, hold considerable cash and deposits. Some have net cash equivalent to 20–30% of market capitalization. A comparison based only on P/E includes that cash in the valuation of the operating business.
The same 15x P/E means different things for a company with substantial cash and one carrying debt. Investors want to understand the multiple the market assigns to the operating business’s earnings power, rather than the price of the company including its cash.
JII Compounders therefore emphasizes EV/EBIT. We calculate EV by adding interest-bearing debt to market capitalization and subtracting cash and deposits, then divide by EBIT, a measure of operating earnings. We seek to minimize the effects of tax rates, extraordinary items, foreign exchange, equity-method income and surplus cash, so that the market valuation corresponds to the business’s earnings power.
The more cash a company holds, the more its valuation can differ when viewed through P/E and EV/EBIT. This effect needs to be separated out when comparing Japanese companies.
Even a good company should be passed over if its price is too high.
Overseas small- and mid-cap investors first decide how much they are willing to pay, then examine capital efficiency and the durability of growth within that price range.
Even when seeking companies that can grow for many years, investors do not begin by considering business quality alone. Many use around 10x EV/EBIT as a guide and exclude companies far above it before detailed analysis. Even an excellent business may deliver poor investment results if the entry price is too high.
Once the price condition is met, the next consideration is capital efficiency. JII emphasizes ROCE: EBIT divided by total assets less current liabilities. ROE is sensitive to financial leverage, while ROIC can be difficult to apply to cash-rich Japanese companies. ROCE is a practical measure of the profit generated from capital employed in the business.
Our guide is ROCE of at least 15%, with no deterioration over the past three years. Looking inexpensive is insufficient. A reasonable purchase price and a business capable of building value while maintaining high capital efficiency are conditions for consideration as a long-term holding.
If a business that sustains high ROCE can be bought at a reasonable multiple, growth may absorb some decline in its valuation multiple. Conversely, even a good company may produce weak investment results if the entry multiple is too high.
Do not pursue low P/B alone.
A low P/B and growth in long-term value per share are different things.
Addressing valuations below book value has become a major theme in Japanese equities. The TSE’s request has helped attract substantial capital to conspicuous low-P/B companies. But low P/B alone does not mean every company has scope for a higher valuation.
A capital-intensive, low-margin, cyclical business may simply be valued in line with its characteristics, even at a low P/B. At ROE of around 5%, value per share is unlikely to grow much without an increase in the multiple. A company sustaining 20% ROE, by contrast, can steadily build book value per share without any change in its multiple.
JII Compounders does not treat low P/B itself as an investment rationale. We examine whether reinvestment can increase value per share. Candidates therefore often include asset-light businesses, companies with high shares of small domestic markets, and companies where a founding family’s long involvement supports consistent capital allocation.
Low P/B can prompt research, but cannot determine the conclusion. Long-term investment depends on continued growth in value per share, rather than simply waiting for a valuation correction.
Look for strengths rooted in the Japanese market.
Companies without an obvious overseas comparable may have distinctive strengths rooted in the Japanese market.
Overseas investors’ screens tend to find companies that are easy to compare with global peers. Semiconductor equipment, pharmaceutical companies and megabanks are easier to understand when similar businesses exist abroad. Companies supported by domestic commercial practices, regulation, distribution, geography or a founding family’s reputation have fewer comparables and are more likely to be missed at the initial selection stage.
Durable earnings do not come only from global recognition or advanced technology. A high share of a small domestic market, close customer relationships and insulation from price competition can support stable margins in a seemingly unremarkable business.
When assessing competitive advantage, JII prioritizes durability. Why is entry difficult? Why are customers unlikely to leave? We examine how strengths that are hard to capture in global peer comparisons generate profit in the domestic market.
Japanese companies that do not fit neatly into global peer tables may retain attractive characteristics. Difficulty finding a comparable can itself explain why overseas investors overlook them.
Use take-private value as a reference for downside.
For a company valued well below public-market peers, the price a control buyer could pay for the whole business is another useful reference for assessing value.
MBOs, private-equity acquisitions and corporate purchases of wholly owned subsidiaries have increased in Japan in recent years. Particularly among small and mid caps, more companies have been taken private after struggling to receive an adequate public-market valuation, with value then improved through changes to capital structure, business portfolios, costs and disclosure policies.
JII uses two prices as references in valuation. One is a reasonable public-market valuation relative to peers. The other is the price a control buyer could pay for the whole company, allowing for improvements after privatization. The latter is a reference for assessing how low the market valuation may be, rather than a prediction of a tender offer.
For take-privates of mid-sized companies with stable cash flow, around 7–10x EV/EBITDA is one practical reference range. When the public-market valuation is well below it, a conceivable acquisition price helps assess downside risk. The analysis does not center on whether an acquisition will occur. We examine whether better capital allocation, margins, segment disclosure and use of surplus funds could restore a peer-like valuation while the company remains listed.
Take-private value is not a number to rely on for predicting an acquisition. We use a price a buyer could reasonably pay as a downside reference while examining the scope to approach peer valuations as a listed company.
What is obvious inside a company may be unclear from its documents.
Earnings materials may contain the figures without explaining their background or how the business works. Drawing on questions raised in translation work and overseas investor meetings, JII examines what is difficult to understand from disclosure alone.
Earnings materials may show the numbers without explaining why they increased, how a business earns money, or where capital will be deployed next. Things taken for granted internally are particularly likely to go unexplained. Investors assess a company through public materials, so they must infer what has not been written and make their own judgment.
These unclear points become questions in overseas investor meetings. More than the revenue or profit figures themselves, investors ask why the figures changed, whether the change will persist, how profitable each business is and how capital will be used. Meetings often revisit matters that the materials did not make clear.
JII does not present views to a company on behalf of a particular investor. We read earnings materials and prior disclosures, considering where overseas investors are likely to ask questions, and look for points that the company believes it has explained but that a first-time reader may find unclear. This approach is common to translation, English review and interpretation.
A Compounder Profile also starts with public information, asking how clearly it explains the company’s sources of earnings, strengths and points requiring attention. Better disclosure does not necessarily raise the share price. But if inadequate explanation prevents the business from being understood, the company can improve that itself. Explain what is needed for investors to reach their own judgment: that is JII’s view of IR improvement.
Something obvious inside a company may be entirely new to an investor. JII believes the basis of IR is explaining it clearly enough for a reader outside the company to understand.
Bring six viewpoints together in one company report.
Each company report has four chapters. We examine price movements, investor debates, disclosure and capital actions that could improve valuation, and share-price scenarios in the same order each time.
The past 24 months of share prices
We read the past 24 months of share prices as a record of how the market has valued the operating business and its capital efficiency. Major movements are checked against results and disclosures, and compared with TOPIX.
What investors are examining
We set out bullish and bearish views and identify the facts that could change the market’s assessment. Key questions include the durability of competitive advantage, whether investors can interpret disclosed figures correctly, and the consistency of capital allocation.
Disclosure and capital-policy actions
We identify where better market understanding could change valuation without waiting for earnings growth. This includes what to disclose, the burden on management and the earliest practical implementation date.
Share-price scenarios
Bear, base and bull cases show what changes in performance and disclosure would move the company toward each outcome. Acquisition value informs downside assessment; peer valuation multiples inform upside assessment.
A universe we follow over time.
Companies meeting the criteria below enter the research universe. We select reports from that group where clarifying what investors need to establish offers particular value.
The company universe includes TSE-listed companies meeting all seven criteria at the latest closing price. At the September 29, 2026 close, there were 110 companies. ROCE uses the latest full-year operating profit divided by total assets less current liabilities; forward EV/EBIT uses company forecasts of operating profit. Companies without verifiable required figures are excluded.
JII selects company reports from the candidate universe through editorial judgment. We examine competitive advantages rooted in the domestic market (Viewpoint 04), scope to improve disclosure and capital policy (Viewpoint 06), and financial information sufficient to construct several share-price scenarios. Companies cannot pay sponsorship fees to secure coverage. Any paid engagement is disclosed at the start of the report; new reports and revisions are suspended during the engagement.
Why does JII publish this analysis?
JII translates Japanese companies’ disclosures and interprets meetings with overseas investors. The questions investors raise are the same as those considered in company analysis. What does the market understand? What remains unclear and prevents judgment? What explanation could narrow a valuation gap? What capital policy could change investors’ views?
JII Compounders conducts this analysis using public information alone and makes the process visible. Analysis needs to be open to subsequent verification. Readers can examine primary disclosures, the next results presentation and subsequent price movements to assess whether JII’s view was reasonable.
Readers gain a practical framework for examining Japanese companies; JII continually exposes its analysis to market scrutiny. JII Compounders is a public notebook serving both purposes.
This material is not investment advice.
Japan Investor Interface Co., Ltd. (“JII”) is an investor-relations (IR) consultancy. JII is not a registered investment advisor, financial advisor, broker-dealer or securities firm in any jurisdiction. JII is not registered as a Financial Instruments Business Operator under Japan’s Financial Instruments and Exchange Act and does not hold an Investment Advisory and Agency Business registration. JII does not provide investment advice or solicit the purchase, sale or holding of any security.
JII Compounders is editorial content for educational and research purposes. Each company report examines how the market has received public disclosures by Japanese listed companies. The intended readers are IR practitioners, finance students, journalists and people interested in corporate disclosure. The content does not recommend, propose or solicit the purchase, sale or holding of any security, derivative or other financial instrument. Price levels, scenarios, valuation multiples and peer comparisons illustrate analytical methods and do not express JII’s investment judgment.
Using this information. The information may be incomplete, out of date or incorrect. Forward-looking statements are uncertain. Past share-price performance does not indicate future results. Estimates and scenario values are not forecasts and may not materialize. JII does not warrant the accuracy, completeness, timeliness or reliability of the information, expressly or implicitly.
Use of this site. Reading this publication does not create an advisory, fiduciary or other professional relationship between the reader and JII. Before making investment, tax, accounting, legal or other decisions, consult appropriately qualified professionals in your jurisdiction as necessary. Check the company’s primary disclosures and conduct your own independent research.
Trademarks and data. Company names, logos, ticker symbols and product names belong to their respective owners. Share-price data is licensed from third-party providers. TradingView is a trademark of TradingView, Inc.
Conflicts of interest. JII, its officers and related parties do not hold or trade securities of companies covered in JII research reports. If JII has a paid engagement with a company it covers, that relationship is disclosed in the relevant report. JII’s publications provide information and do not constitute investment advice or a recommendation to buy or sell any security.